TABLE 1.
Subtype(s) | Definition | Distinguishing characteristic(s) | Clinical finding(s) | Reference(s) |
---|---|---|---|---|
CRSsNP | Chronic rhinosinusitis without nasal polyps | Polyposis | Tends to be Th1-skewed neutrophilic disease with fibrosis and often high levels of collagen deposition, basement membrane thickening, and goblet cell hyperplasia | 2, 45–47 |
CRSwNP | Chronic rhinosinusitis with nasal polyps | Polyposis | Tends to be eosinophilic disease associated with edema and elevated inflammatory signaling; generally Th2-skewed immune response in Caucasian populations but Th1 in Chinese populations and Th17 in cystic fibrosis patients; presence of polyposis in patients tends to be associated with worse preoperative CT and both pre- and postoperative symptom scores | 2, 4, 7, 45–51 |
eCRSsNP | Eosinophilic chronic rhinosinusitis without nasal polyps | Polyposis, eosinophilia | Appears to be uncommon | |
neCRSsNP | Noneosinophilic chronic rhinosinusitis without nasal polyps | Polyposis, eosinophilia | Tends to be representative of most CRSsNP patients | 46, 51 |
eCRSwNP | Eosinophilic chronic rhinosinusitis with nasal polyps | Polyposis, eosinophilia | Tends to be representative of most cases of CRSwNP in Caucasian populations; eosinophilia correlates with both frequency of polyps and comorbid asthma and tends to be associated with worse preoperative CT and both pre- and postoperative symptom scores than neCRSwNP | 2, 4, 7, 45–51 |
neCRSwNP | Noneosinophilic chronic rhinosinusitis with nasal polyps | Polyposis, eosinophilia | Tends to be the most common form of CRSwNP in Chinese populations (Th1) and cystic fibrosis patients (Th17) | 2, 4, 7, 45, 47–51 |
CHES, ECHRS | Chronic hyperplastic eosinophilic sinusitis, eosinophilic chronic hyperplastic rhinosinusitis | Hyperplasia | Comparable to eCRSwNP | 49, 52 |
CIS, NECHRS | Chronic inflammatory sinusitis, noneosinophilic chronic hyperplastic rhinosinusitis | Hyperplasia | Comparable to neCRSwNP | 49, 52 |
eCRSsNP, neCRSsNP, eCRSwNP, neCRSwNP, CHES, ECHRS, CIS, and NECHRS with or without polyposis, eosinophilia, neutrophilia, asthma, atopy, allergic fungal rhinosinusitis, aspirin-exacerbated respiratory disease, cystic fibrosis | Polyposis, eosinophilia, neutrophilia, asthma, atopy, allergic fungal rhinosinusitis, aspirin-exacerbated respiratory disease, cystic fibrosis | Asthmatic, aspirin-exacerbated respiratory disease, and allergic fungal rhinosinusitis patients tend to have higher CT and endoscopy scores and higher rates of polyposis and eosinophilia; nonasthmatic patients, in contrast, tend to have disease more associated with purulence but with lower CT scores than those of their asthmatic counterparts; cystic fibrosis patients represent a mix of the above-described patterns, associated with both purulence and higher CT scores | 53 | |
CRS, delineated into 10 distinct subclusters of underlying inflammatory profiles | Distinct profiles of tissue inflammatory markers | 44 |
CT, computed tomography.